Conservative interventions for managing urinary incontinence after prostate surgery

Johnson, Eugenie; Mamoulakis, Charalampos; Omar, Muhammad Imran; Sinha, Sanjay

doi:10.1002/14651858.cd014799

Cited by 2 publications

(2 citation statements)

References 31 publications

(1 reference statement)

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Prior studies have suggested that regular administration of nasteride before surgery can effectively reduce the risk of intraoperative bleeding during TURP [5]. This is postulated to occur through the reduction of prostatic microvascular density [6], ultimately decreasing intraoperative blood loss [7][8][9].…”

Section: Introductionmentioning

confidence: 99%

“…Prior research literature has highlighted the advantages of laser-assisted transurethral prostatectomy, including its unique ability to vaporize and seal blood vessels as well as precisely cut tissues [2,7]. These advantages have translated into a reduced incidence of intraoperative bleeding, postoperative urethral stricture, and urinary incontinence compared to the traditional TURP procedure [3,8,9]. Therefore, the necessity of continued preoperative administration of nasteride has become a subject of scrutiny, given its potential implications for increased patient compliance, preoperative preparation time, hospital stay, and healthcare costs.…”

Section: Introductionmentioning

confidence: 99%

See 1 more Smart Citation

The regular use of Finasteride before Transurethral Laser Resection of the Prostate help to reduce bleeding: a retrospective study in a single center

Wang,

Gong,

Chen

et al. 2024

Preprint

View full text Add to dashboard Cite

Purpose: To investigate the effect of preoperative administration of finasteride on intraoperative bleeding during transurethral laser resection of the prostate. Materials and methods: We retrospectively analyzed 181 patients who underwent transurethral laser resection of the prostate between Jan 2021 and Dec 2023. Patients were divided into two groups based on whether finasteride were used (n = 99) or not (n = 82). The following parameters were collected: age, height, weight and body mass index (BMI), international prostate symptom score (IPSS), quality of life (QoL) score, prostate‐specific antigen (PSA), prostate volume, operation time, hospital stay, catheterization duration, re‐catheterization , preoperative and postoperative hemoglobin concentrations, preoperative and postoperative serum sodium concentrations, postoperative urinary tract infection (UTI) rate, hospitalization costs. We compared the two groups using Student’s t test, Mann–Whitney U test and χ2 test for quantitative and categorical variables, respectively. Linear regression model was used to identify predictive factors of transurethral laser resection of the prostate. Results: Compared with the non-finasteride group, the finasteride group had a lower bleeding level (Δhemoglobin 3.63±8.73 g/L vs. 8.10±11.14 g/L, p=0.026), and a lower hospitalization costs (22796.89±5482.40 Yuan vs. 25113.27±4510.60 Yuan, p=0.008). In multivariate analyses, the regular use of finasteride (r=-0.237, p=0.002) and level of PSA (r=0.233, p=0.006) was the indepentent predictive factor of intraoperative bleeding during transurethral laser resection of the prostate. Conclusion: The regular use of finasteride before transurethral laser resection of the prostate help to reduce intraoperative bleeding level.

show abstract

Section: Introductionmentioning

confidence: 99%